Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.

Autor: Edward De Brouwer, Thijs Becker, Lorin Werthen-Brabants, Pieter Dewulf, Dimitrios Iliadis, Cathérine Dekeyser, Guy Laureys, Bart Van Wijmeersch, Veronica Popescu, Tom Dhaene, Dirk Deschrijver, Willem Waegeman, Bernard De Baets, Michiel Stock, Dana Horakova, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Marc Girard, Alexandre Prat, Alessandra Lugaresi, Pierre Grammond, Tomas Kalincik, Raed Alroughani, Francois Grand'Maison, Olga Skibina, Murat Terzi, Jeannette Lechner-Scott, Oliver Gerlach, Samia J Khoury, Elisabetta Cartechini, Vincent Van Pesch, Maria José Sà, Bianca Weinstock-Guttman, Yolanda Blanco, Radek Ampapa, Daniele Spitaleri, Claudio Solaro, Davide Maimone, Aysun Soysal, Gerardo Iuliano, Riadh Gouider, Tamara Castillo-Triviño, José Luis Sánchez-Menoyo, Anneke van der Walt, Jiwon Oh, Eduardo Aguera-Morales, Ayse Altintas, Abdullah Al-Asmi, Koen de Gans, Yara Fragoso, Tunde Csepany, Suzanne Hodgkinson, Norma Deri, Talal Al-Harbi, Bruce Taylor, Orla Gray, Patrice Lalive, Csilla Rozsa, Chris McGuigan, Allan Kermode, Angel Pérez Sempere, Simu Mihaela, Magdolna Simo, Todd Hardy, Danny Decoo, Stella Hughes, Nikolaos Grigoriadis, Attila Sas, Norbert Vella, Yves Moreau, Liesbet Peeters

Publikováno v: PLOS Digital Health, Vol 3, Iss 7, p e0000533 (2024)

BackgroundDisability progression is a key milestone in the disease evolution of people with multiple sclerosis (PwMS). Prediction models of the probability of disability progression have not yet reached the level of trust needed to be adopted in the

Externí odkaz: https://doaj.org/article/c8086e53dc844308be0ea446e3a32319

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

Autor: M. Lefort, S. Sharmin, J. B. Andersen, S. Vukusic, R. Casey, M. Debouverie, G. Edan, J. Ciron, A. Ruet, J. De Sèze, E. Maillart, H. Zephir, P. Labauge, G. Defer, C. Lebrun-Frenay, T. Moreau, E. Berger, P. Clavelou, J. Pelletier, B. Stankoff, O. Gout, E. Thouvenot, O. Heinzlef, A. Al-Khedr, B. Bourre, O. Casez, P. Cabre, A. Montcuquet, A. Wahab, J. P. Camdessanché, A. Maurousset, H. Ben Nasr, K. Hankiewicz, C. Pottier, N. Maubeuge, D. Dimitri-Boulos, C. Nifle, D. A. Laplaud, D. Horakova, E. K. Havrdova, R. Alroughani, G. Izquierdo, S. Eichau, S. Ozakbas, F. Patti, M. Onofrj, A. Lugaresi, M. Terzi, P. Grammond, F. Grand’Maison, B. Yamout, A. Prat, M. Girard, P. Duquette, C. Boz, M. Trojano, P. McCombe, M. Slee, J. Lechner-Scott, R. Turkoglu, P. Sola, D. Ferraro, F. Granella, V. Shaygannejad, J. Prevost, D. Maimone, O. Skibina, K. Buzzard, A. Van der Walt, R. Karabudak, B. Van Wijmeersch, T. Csepany, D. Spitaleri, S. Vucic, N. Koch-Henriksen, F. Sellebjerg, P. S. Soerensen, C. C. Hilt Christensen, P. V. Rasmussen, M. B. Jensen, J. L. Frederiksen, S. Bramow, H. K. Mathiesen, K. I. Schreiber, H. Butzkueven, M. Magyari, T. Kalincik, E. Leray

Publikováno v: BMC Medical Research Methodology, Vol 22, Iss 1, Pp 1-14 (2022)

Abstract Background Natalizumab and fingolimod are used as high-efficacy treatments in relapsing–remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control t

Externí odkaz: https://doaj.org/article/84c3797631444a10b4fb616e78d4bf21

Association between occupational exposures and sarcoma incidence and mortality: systematic review and meta-analysis

Autor: D. Edwards, A. Voronina, K. Attwood, A. Grand’Maison

Publikováno v: Systematic Reviews, Vol 10, Iss 1, Pp 1-19 (2021)

Abstract Background Sarcomas are a rare and heterogeneous group of tumors originating from mesenchymal or connective tissue. They represent less than 1% of all adult cancers. The etiology and epidemiology of sarcomas remain understudied and poorly un

Externí odkaz: https://doaj.org/article/e4b215bf30824f0eb19600afe79f584a

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis

Autor: Marco Onofrj, Dana Horakova, Pierre Duquette, Pierre Grammond, Serkan Ozakbas, Murat Terzi, Jeannette Lechner-Scott, Cavit Boz, Patrizia Sola, Franco Granella, Roberto Bergamaschi, Recai Turkoglu, Vincent Van Pesch, Raed Alroughani, Bassem Yamout, Radek Ampapa, Suzanne Hodgkinson, Helmut Butzkueven, Jim Stankovich, Albert Saiz, Michael Barnett, Richard Macdonell, Maria Pia Amato, Anneke Van Der Walt, Francesco Patti, Ayse Altintas, Pamela McCombe, Wei Z Yeh, Olga Skibina, Celia Oreja-Guevara, Tamara Castillo-Trivino, Putu A Widyastuti, Eva K Havrdova, Karolina Vodehnalova, Sara Eichau, Maria J Sá, Francois Grand’Maison, Daniele LA Spitaleri, Elisabetta Cartechini, Aysun Soysal, Melissa Gresle, Tomas Uher, Davide Maimone, Raymond MM Hupperts, Vilija G Jokubaitis, MSBase Registry

Publikováno v: BMJ Neurology Open, Vol 3, Iss Suppl 1 (2021)

Externí odkaz: https://doaj.org/article/73f419e780b84c59bc44cdd952fe9689